Ebola virus: Melatonin as a readily available treatment option

Journal of Medical Virology

Volumn 87, Issue 4, 2015, Pages 537-543

  Anderson, George ^a   Maes, Michael ^b,c,d   Markus, Regina P ^e   Rodriguez, Moses ^f  

^a Eccleston Square   (United Kingdom)

^b DEAKIN UNIVERSITY   (Australia)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d STATE UNIVERSITY OF LONDRINA   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

^f MAYO GRADUATE SCHOOL   (United States)

Author keywords

Anti inflammatory; Ebola; Heme oxygenase 1; Melatonin; Treatment

Indexed keywords

HEME OXYGENASE 1; MELATONIN; NICOTINIC RECEPTOR; IMMUNOLOGIC FACTOR;

ARTICLE; DISEASE COURSE; DRUG COST; DRUG RECEPTOR BINDING; EBOLA HEMORRHAGIC FEVER; EBOLA VIRUS; HUMAN; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; SEPSIS; SEPTIC SHOCK; VIRUS REPLICATION; AFRICA; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY;

BACTERIA (MICROORGANISMS); EBOLA VIRUS;

AFRICA, WESTERN; HEMORRHAGIC FEVER, EBOLA; HUMANS; IMMUNOLOGIC FACTORS; MELATONIN;

EID: 84922882229     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24130     Document Type: Article

References (84)

1. Al-Omary FA. 2013. Melatonin: Comprehensive profile. Profiles Drug Subst Excip Relat Methodol 38:159-226.
2. Anderson G, Maes M. 2014a. Reconceptualizing adult neurogenesis: Role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions. CNS Neurol Disord Drug Targets 13:126-136.
3. Anderson G, Maes M. 2014b. Local melatonin regulates inflammation resolution: A common factor in neurodegenerative, psychiatric and systemic inflammatory disorders. CNS Neurol Disord Drug Targets 13:817-827.
4. Ansari AA. 2014. Clinical features and pathobiology of Ebola virus infection. J Autoimmun 55C:1-9.
5. Applegate LA, Luscher P, Tyrrell RM. 1991. Induction of heme oxygenase: A general response to oxidant stress in cultured mammalian cells. Cancer Res 51:974-978.
6. Arlt O, Schwiebs A, Japtok L, Rüger K, Katzy E, Kleuser B, Radeke HH. 2014. Sphingosine-1-phosphate modulates dendritic cell function: Focus on non-migratory effects in vitro and in vivo. Cell Physiol Biochem 34:27-44.
7. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P. 2000. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97:12289-12294.
8. Bertrand PP, Polglaze KE, Bertrand RL, Sandow SL, Pozo MJ. 2014. Detection of melatonin production from the intestinal epithelium using electrochemical methods. Curr Pharm Des 20:4802-4806.
9. Bertuglia S, Marchiafava PL, Colantuoni A. 1996. Melantonin prevents ischemia reperfusion injury in hamster cheek pouch microcirculation. Cardiovasc Res 31:947-952.
10. Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ. 2012. Beneficial actions of melatonin in the management of viral infections: A new use for this "molecular handyman"? Rev Med Virol 22:323-338.
11. Bray M, Mahanty S. 2003. Ebola hemorrhagic fever and septic shock. J Infect Dis 188:1613-1617.
12. Calvo JR, González-Yanes C, Maldonado MD. 2013. The role of melatonin in the cells of the innate immunity: A review. J Pineal Res 55:103-120.
13. Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, García-Mauriño S, Reiter RJ, Guerrero JM. 2004. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: Possible role as intracrine, autocrine, and/or paracrine substance. FASEB J 18:537-539.
14. Carrillo-Vico A, Lardone PJ, Alvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM. 2013. Melatonin: Buffering the immune system. Int J Mol Sci 14:8638-8683.
15. Chen JK, Li ZP, Liu YZ, Zhao T, Zhao XB, Ni M, Jiang GJ, Shen FM. 2014. Activation of alpha 7 nicotinic acetylcholine receptor protects mice from radiation-induced intestinal injury and mortality. Radiat Res 181:666-671.
16. Cho SY, Lee HJ, Jeong SJ, Lee HJ, Kim HS, Chen CY, Lee EO, Kim SH. 2011. Sphingosine kinase 1 pathway is involved in melatonin-induced HIF-1α inactivation in hypoxic PC-3 prostate cancer cells. J Pineal Res 51:87-93.
17. Chung SW, Hall SR, Perrella MA. 2009. Role of haem oxygenase-1 in microbial host defence. Cell Microbiol 11:199-207.
18. Cui WY, Zhao S, Polanowska-Grabowska R, Wang J, Wei J, Dash B, Chang SL, Saucerman JJ, Gu J, Li MD. 2013. Identification and characterization of poly(I:C)-induced molecular responses attenuated by nicotine in mouse macrophages. Mol Pharmacol 83:61-72.
19. Csaba G. 2013. The pineal regulation of the immune system: 40 years since the discovery. Acta Microbiol Immunol Hung 60:77-91.
20. Dagnell C, Grunewald J, Kramar M, Haugom-Olsen H, Elmberger GP, Eklund A. 2009. Role of CD4(+) T cells in the modulation of neurotrophin production in mice exposed to low-level toluene. Immunopharmacol Immunotoxicol 31:146-149.
21. de Oliveira Tatsch-Dias M, Levandovski RM, Custódio de Souza IC, Gregianin Rocha M, Magno Fernandes PA, Torres IL, Hidalgo MP, Markus RP, Caumo W. 2013. The concept of the immune-pineal axis tested in patients undergoing an abdominal hysterectomy. Neuroimmunomodulation 220:205-212.
22. del Gobbo V, Libri V, Villani N, Caliò R, Nisticò G. 1989. Pinealectomy inhibits interleukin-2 production and natural killer activity in mice. Int J Immunopharmacol 11:567-573.
23. Devadas K, Dhawan S. 2006. Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction. J Immunol 176:4252-4257.
24. Ding K, Wang H, Xu J, Li T, Zhang L, Ding Y, Zhu L, He J, Zhou M. 2014. Melatonin stimulates antioxidant enzymes and reduces oxidative stress in experimental traumatic brain injury: The Nrf2-ARE signaling pathway as a potential mechanism. Free Radic Biol Med 73:1-11.
25. Eskan MA, Rosem BG, Benakanakere MR. 2008. TLR4 and S1P receptors cooperate to enhance inflammatory cytokine production in human gingival epithelial cells. Eur J Immunol 38:1138-1147.
26. Galano A, Tan DX, Reiter RJ. 2013. On the free radical scavenging activities of melatonin's metabolites. AFMK and AMK. J Pineal Res 54:245-257.
27. Galley HF, Lowes DA, Allen L, Cameron G, Aucott LS, Webster NR. 2014. Melatonin as a potential therapy for sepsis: A phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J Pineal Res 56:427-438.
28. Gergalova G, Lykhmus O, Kalashnyk O, Koval L, Chernyshov V, Kryukova E, Tsetlin V, Komisarenko S, Skok M. 2012. Mitochondria express α7 nicotinic acetylcholine receptors to regulate Ca2+ accumulation and cytochrome c release: Study on isolated mitochondria. PLoS ONE 7:e31361.
29. Gitto E, Karbownik M, Reiter RJ, Tan DX, Cuzzocrea S, Chiurazzi P, Cordaro S, Corona G, Trimarchi G, Barberi I. 2001. Effects of melatonin treatment in septic newborns. Pediatr Res 50:756-760.
30. Hardeland R. 2009. Melatonin: Signaling mechanisms of a pleiotropic agent. Biofactors 35:183-192.
31. Hensley LE, Geisbert TW. 2005. The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primates. Thromb Haemost 94:254-261.
32. Hill-Batorski L, Halfmann P, Neumann G, Kawaoka Y. 2013. The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication. J Virol 87:13795-13802.
33. Hsu JT, Kuo CJ, Chen TH, Wang F, Lin CJ, Yeh TS, Hwang TL, Jan YY. 2012. Melatonin prevents hemorrhagic shock-induced liver injury in rats through an Akt-dependent HO-1 pathway. J Pineal Res 53:410-416.
34. Hughes JE, Srinivasan S, Lynch KR, Proia RL, Ferdek P, Hedrick CC. 2008. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ Res 102:950-958.
35. Hutchinson KL, Villinger F, Miranda ME, Ksiazek TG, Peters CJ, Rollin PE. 2001. Multiplex analysis of cytokines in the blood of cynomolgus macaques naturally infected with Ebola virus (Reston serotype). J Med Virol 65:561-566.
36. Iuvone PM, Boatright JH, Tosini G, Ye K. 2014. N-acetylserotonin: Circadian activation of the BDNF receptor and neuroprotection in the retina and brain. Adv Exp Med Biol 801:765-771.
37. Kang JW, Lee SM. 2012. Melatonin inhibits type 1 interferon signaling of toll-like receptor 4 via heme oxygenase-1 induction in hepatic ischemia/reperfusion. J Pineal Res 53:67-76.
38. Kilic U, Kilic E, Tuzcu Z, Tuzcu M, Ozercan IH, Yilmaz O, Sahin F, Sahin K. 2013. Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway. Nutr Metab (Lond) 10:17.
39. Kreuels B, Wichmann D, Emmerich P, Schmidt-Chanasit J, de Heer G, Kluge S, Sow A, Renné T, Günther S, Lohse AW, Addo MM, Schmiedel S. 2014. A case of severe Ebola virus infection complicated by Gram-Negative Septicemia. N Engl J Med 371:2394-2401.
40. Larsen T, Stevens EL, Davis KJ, Geisbert JB, Daddario-DiCaprio KM, Jahrling PB, Hensley LE, Geisbert TW. 2007. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. J Infect Dis 196:S323-S328.
41. Lee RH, Vazquez G. 2013. Evidence for a prosurvival role of alpha-7 nicotinic acetylcholine receptor in alternatively (M2)-activated macrophages. Physiol Rep 1:e00189.
42. Lehmann E, El-Tantawy WH, Ocker M, Bartenschlager R, Lohmann V, Hashemolhosseini S, Tiegs G, Sass G. 2010. The heme oxygenase 1 product biliverdin interferes with hepatitis C virus replication by increasing antiviral interferon response. Hepatology 51:398-404.
43. Li YZ, Liu XH, Rong F, Hu S, Sheng ZY. 2010. Carbachol inhibits TNF-α-induced endothelial barrier dysfunction through alpha 7 nicotinic receptors. Acta Pharmacol Sin 31:1389-1394.
44. Liu Z, Han B, Li P, Wang Z, Fan Q. 2014. Activation of α7nAChR by nicotine reduced the Th17 response in CD4(+)T lymphocytes. Immunol Invest 43:667-674.
45. Lotufo CMC, Yamashita CE, Farsky SHP, Markus RP. 2006. Melatonin effect on endothelial cells reduces vascular permeability increase induced by leukotriene B4-European. J Pharmacol 534:258-263.
46. Lotufo CMC, Lopes C, Dubocovich ML, Farsky SH, Markus RP. 2001. Melatonin and N-acetylserotonin inhibit leukocyte rolling and adhesion to rat microcirculation. European J Pharmacol 430:351-357.
47. Markus RP, Ferreira ZS. 2011. The Immune-Pineal Axis: The role of pineal and extra-pineal melatonin in modulating inflammation. Adv Neuroimmuno Biol 1:95-104.
48. Markus RP, Silva CL, Franco DG, Barbosa EM Jr, Ferreira ZS. 2010. Is modulation of nicotinic acetylcholine receptors by melatonin relevant for therapy with cholinergic drugs? Pharmacol Ther 126:251-262.
49. Markus RP, Ferreira ZS, Fernandes PA, Cecon E. 2007. The immune-pineal axis: A shuttle between endocrine and paracrine melatonin sources. Neuroimmunomodulation 14:126-133.
50. Martín M, Macías M, León J, Escames G, Khaldy H, Acuña-Castroviejo D. 2002. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 34:348-357.
51. Martines RB, Ng DL, Greer PW, Rollin PE, Zaki SR. 2015. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg Viruses. J Pathol 235:153-174.
52. Mauriz JL, Collado PS, Veneroso C, Reiter RJ, González-Gallego J. 2013. A review of the molecular aspects of melatonin's anti-inflammatory actions: Recent insights and new perspectives. J Pineal Res 54:1-14.
53. Muxel SM, Pires-Lapa MA, Monteiro AW, Cecon E, Tamura EK, Floeter-Winter LM, Markus RP. 2012. NF-κB drives the synthesis of melatonin in RAW 264.7 macrophages by inducing the transcription of the arylalkylamine-N-acetyltransferase (AA-NAT) gene. PLoS ONE 7:e52010.
54. Oldstone MB, Teijaro JR, Walsh KB, Rosen H. 2013. Dissecting influenza virus pathogenesis uncovers a novel chemical approach to combat the infection. Virology 435:92-101.
55. Parada E, Buendia I, León R, Negredo P, Romero A, Cuadrado A, López MG, Egea J. In press. Neuroprotective effect of melatonin against ischemia is partially mediated by alpha-7 nicotinic receptor modulation and HO -1 overexpression. J Pineal Res.
56. Peña VB, Bonini IC, Antollini SS, Kobayashi T, Barrantes FJ. 2011. Alpha 7-type acetylcholine receptor localization and its modulation by nicotine and cholesterol in vascular endothelial cells. J Cell Biochem 112:3276-3288.
57. Peters CJ, Zaki SR. 2002. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 30:S268-S273.
58. Pietzcker J, Kluthea C, Klinghammer K, Bührer C, Rüstow B, Guthmann F. 2012. Developmental delay in hypoxia-induced HO-1 expression predisposes to gut injury. J Perinat Med 40:191-197.
59. Pinato L, da Silveira Cruz-Machado S, Franco DG, Campos LM, Cecon E, Fernandes PA, Bittencourt JC, Markus RP. In press. Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis. Brain Struct Funct.
60. Pires-Lapa MA, Tamura EK, Salustiano EM, Markus RP. 2013. Melatonin synthesis in human colostrum mononuclear cells enhances dectin-1-mediated phagocytosis by mononuclear cells. J Pineal Res 55:240-246.
61. Pontes GN, Cardoso E, Carneiro-Sampaio MMS, Markus RP. 2006. Injury switches Melatonin Production Source from Endocrine (pineal) to Paracrine (phagocytes) - Melatonin in Human Colostrum and Colostrum Phagocytes. J Pineal Res 41:136-141.
62. Reiter RJ, Tan DX, Rosales-Corral S, Manchester LC. 2013. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 13:373-384.
63. Silva CLM, Tamura EK, Macedo SMD, Cecon E, Bueno-Alves L, Farsky SHP, Ferreira ZS, Markus RP. 2007. Melatonin inhibits nitric oxide production by microvascular endothelial cells in vivo and in vitro. Br J Pharmacol 151:195-205.
64. Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, Fortune JA, Klibanov AM, Garcia JG, Birukov KG. 2009. Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 104:978-986.
65. Sommansson A, Saudi WS, Nylander O, Sjöblom M. 2013a. Melatonin inhibits alcohol-induced increases in duodenal mucosal permeability in rats in vivo. Am J Physiol Gastrointest Liver Physiol 305:G95-G105.
66. Sommansson A, Nylander O, Sjöblom M. 2013b. Melatonin decreases duodenal epithelial paracellular permeability via a nicotinic receptor-dependent pathway in rats in vivo. J Pineal Res 54:282-291.
67. Srinivasan V, Spence DW, Pandi-Perumal SR, Trakht I, Cardinali DP. 2008. Therapeutic actions of melatonin in cancer: Possible mechanisms. Integr Cancer Ther 7:189-203.
68. Stuss M, Wiktorska JA, Sewerynek E. 2010. N-acetylserotonin reduces lipopolysaccharide-induced lipid peroxidation in vitro more effectively than melatonin. Neuro Endocrinol Lett 31:489-496.
69. Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, Hirano K, Usui S, Wang F, Du W, Yoshioka K, Banno Y, Sasaki M, Ichi I, Okamura M, Sugimoto N, Mizugishi K, Nakanuma Y, Ishii I, Takamura M, Kaneko S, Kojo S, Satouchi K, Mitumori K, Chun J, Takuwa Y. 2010. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res 85:484-493.
70. Tamura EK, Cecon E, Monteiro AW, Silva CL, Markus RP. 2009. Melatonin inhibits LPS-induced NO production in rat endothelial cells. J Pineal Res 46:268-274.
71. Tamura EK, Fernandes PA, Marçola M, da Silveira Cruz-Machado S, Markus RP. 2010. Long-Lasting Priming of Endothelial Cells by Plasma Melatonin Levels. PLoS ONE 5:e13958.
72. Tan DX, Korkmaz A, Reiter RJ, Manchester LC. 2014. Ebola virus disease: Potential use of melatonin as a treatment. J Pineal Res 57:381-384.
73. Tan DX, Manchester LC, Liu X, Rosales-Corral SA, Acuna-Castroviejo D, Reiter RJ. 2013. Mitochondria and chloroplasts as the original sites of melatonin synthesis: A hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res 54:127-138.
74. Tortorolo L, Langer A, Polidori G, Vento G, Stampachiacchere B, Aloe L. 2005. Neurotrophin overexpression in lower airways of infants with respiratory syncytial virus infection. Am J Respir Crit Care Med 172:233-237.
75. Tung WH, Hsieh HL, Lee IT, Yang CM. 2011. Enterovirus 71 induces integrin β1/EGFR-Rac1-dependent oxidative stress in SK-N-SH cells: Role of HO-1/CO in viral replication. J Cell Physiol 226:3316-3329.
76. Vadillo E, Dorantes-Acosta E, Arriaga-Pizano L, Chavez-Gonzalez A, Reyes-Maldonado E, Garrett KP, Mayani H, Kincade PW, Pelayo R. 2014. Adult, but not neonatal, human lymphoid progenitors respond to TLR9 ligation by producing functional NK-like cells. Exp Hemato 42:562-573.
77. Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B. 2014. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human HSV-1 infections. Immunology 143:588-600.
78. Warfield KL, Perkins JG, Swenson DL, Deal EM, Bosio CM, Aman MJ, Yokoyama WM, Young HA, Bavari S. 2004. Role of natural killer cells in innate protection against lethal Ebola virus infection. J Exp Med 200:169-179.
79. Wauquier N, Padilla C, Becquart P, Leroy E, Vieillard V. 2010. Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. Immunogenetics 62:767-771.
80. WHO Ebola Response Team . 2014. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med 371:1481-1495.
81. Yamin D, Gertler S, Ndeffo-Mbah ML, Skrip LA, Fallah M, Nyenswah TG, Altice FL, Galvani AP. In press. Effect of Ebola Progression on Transmission and Control in Liberia. Ann Intern Med.
82. Zhang HM, Zhang Y. 2014. Melatonin: A well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 57:131-146.
83. Zhang QH, Zhou ZS, Lu GS, Song B, Guo JX. 2013. Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats. Inflammation 36:651-657.
84. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN. 2008. Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. Hepatology 48:1430-1439.